What is US8158616B2, and how does it relate to baricitinib?
US8158616B2 is a US patent that (based on its bibliographic record on Google Patents) is associated with the patent family covering baricitinib (a JAK inhibitor used for inflammatory diseases). On Google Patents, the record typically links you to the application, assignees, filing/priority dates, and the claims that define the protected subject matter.
If you share the patent title or the assignee name shown on Google Patents for US8158616B2, I can map the claims to the specific baricitinib aspect (for example, the compound itself vs. formulations, methods of treatment, or specific dosing/use claims).
How to find the key details on Google Patents for US8158616B2
On Google Patents, the fastest way to extract what you need is to look at:
- “Assignee” (who owns it)
- “Inventor(s)”
- “Priority date” and “Filing date”
- “Publication number(s)” in the family (international filings)
- The “Claims” section (what is actually protected)
- “Status”/events (where available)
Search on Google Patents with:
- US8158616B2
- or the family’s related publication numbers shown in the record
Who owns US8158616B2 (and what assignee names to check)?
Ownership matters because baricitinib patent portfolios can be split across related families and jurisdictions. Google Patents will list an assignee for US8158616B2; check whether it matches the company commercializing baricitinib and whether there are later continuation or amended filings in the same family.
Does DrugPatentWatch have a baricitinib entry tied to this patent?
DrugPatentWatch tracks drug-related patents and exclusivity. If you want, tell me the drug name shown in the Google Patents page for US8158616B2 (or paste the Google Patents URL), and I can help you cross-check whether DrugPatentWatch links that same patent to baricitinib and/or to exclusivity periods.
What you probably want to know next: expiration or exclusivity
People usually look up a patent like US8158616B2 to understand:
- whether it blocks generic or biosimilar entry for baricitinib
- the likely patent expiration date (and whether exclusivity extends beyond it)
To calculate this correctly for baricitinib, you need either:
- the patent’s filing/priority dates (and whether term adjustments apply), or
- the exact Google Patents events/status shown for US8158616B2.
Quick next step
If you paste the Google Patents link for US8158616B2 (or the title + assignee), I’ll extract and summarize:
- what the claims cover (baricitinib compound vs. method vs. formulation)
- the key dates from the record
- how it likely affects baricitinib competition (based on what’s visible in the provided sources)
Sources
No usable source links were provided with your message (only “Google patents us8158616b2 baricitinib”), so I can’t cite Google Patents or DrugPatentWatch yet.